President Trump’s seesawing policy on the implementation of tariffs fails to account for the many complexities of international trade, three industry analysts said at TPM25.
The rise of digital supply chain networks represents a significant shift in how the pharma and life sciences industry approaches supply chain management.
It’s time to confront the harsh truths, and pivot toward strategies like reshoring and nearshoring that promise to mitigate risks and restore competitive advantage.
As operating landscapes become increasingly turbulent, companies in every region are reviewing their supply chain strategies for navigating uncertainty and sudden change.